Ga 12 , the a-subunit of G12, which has been referred to as the gep oncogene, stimulates mitogenic pathways in different cell types and readily induces neoplastic transformation of fibroblast cell lines. Recently, we have shown that the oncogenic pathway activated by Ga 12 involves the receptor tyrosine kinase platelet derived growth factor receptor-a (PDGFRa) and JAK3. In the present study, we demonstrate that the GTPase-deficient activated mutant of Ga 12 activates signal transducer and activator of transcription 3 (STAT3) via PDGFRa as well as JAK3. Here we show that Ga 12 stimulates the phosphorylation of STAT3 at both Tyrosine-705 and Serine-727 residues. Studies to delineate the mechanism by which Ga 12 stimulates STAT3 have indicated that the Tyrosine-705-phosphorylation of STAT3 involves the tyrosine kinases, Janus Kinase-3 as well as Src kinase, whereas the Serine-727 phosphorylation of STAT3 occurs via the receptor tyrosine kinase, PDGFRa and phosphatidylinositol 3-OH kinase pathway. Our results also indicate that the coexpression of the dominant negative, DNA binding mutant of STAT3 (STAT3DB) inhibits the foci formation as well as anchorage-independent growth of Ga 12 QL-transfectants, thereby establishing the critical role of STAT3 in Ga 12 QL-mediated neoplastic cell growth. The results presented here demonstrate, for the first time, the ability of Ga 12 to recruit multiple receptor-, nonreceptor-, and Ser/Thr kinases to stimulate STAT3-signaling to promote neoplastic transformation.
Introduction
Heterotrimeric guanine nucleotide-binding proteins (G proteins) transduce signals from seven transmembrane receptors to specific effectors to elicit a diverse array of cellular responses (Johnson and Dhanasekaran, 1989) . Of the four subfamilies of G proteins, the G12 family of G proteins, defined by the a-subunit Ga 12 and Ga 13 , has been shown to regulate cell growth, differentiation, and migration (Dhanasekaran and Dermott, 1996; Radhika and Dhanasekaran, 2001 ). More significantly, Ga 12 , the a-subunit of G12, has been shown to stimulate mitogenic pathways in multiple cell types and readily induces neoplastic transformation of fibroblast cell lines (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994) . In view of the findings that Ga 12 was isolated as the transforming 'oncogene' from the Ewings sarcoma cell line (Chan et al., 1993) and that Ga 12 potently stimulates the neoplastic transformation of fibroblast cell lines (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994) , it has been designated as 'gep' oncogene (Xu et al., 1994; Gutkind et al., 1998) . Similar to many of the well-characterized oncogenes, Ga 12 stimulates a multitude of signaling pathways that converge on to the activation of mitogenic signaling machinery (Dhanasekaran and Dermott, 1996; Radhika and Dhanasekaran, 2001) . Recently, our analysis of the transcript profile of Ga 12 QL transformed NIH3T3 cells has pointed to a role for the platelet derived growth factor receptor-a (PDGFRa) in Ga 12 QL-mediated cell proliferation (Kumar et al., 2004) . Since previous studies have shown that PDGF-PDGFR signaling pathway stimulates signal tranducers and activators of transcription (STATs) and activated STATs play a critical role in cell cycle progression and prevention of apoptosis (Valgeirsdottir et al., 1998; Vignais and Gilman, 1999; Bromberg and Darnell, 2000) , we investigated whether Ga 12 QL recruits and activates STATs through a pathway involving PDGFRa. Here we report that PDGFRa and STAT3 associate with each other in Ga 12 QL-NIH3T3 cells and Ga 12 QL activates STAT3 by stimulating the phosphorylation of both , and Serine-727 (Ser-727) residues. We also establish that Ga 12 stimulates the Tyr-phosphorylation of STAT3 through Src kinase and Janus Kinase-3 (JAK3)-dependent mechanisms while it stimulates Ser-phosphorylation via a pathway involving PDGFRa and phosphatidylinositol-3-OH-kinase (PI3K). We also show that the coexpression of a dominant-negative mutant of STAT3 (STAT3DB) inhibits the foci formation as well as anchorage-independent growth of Ga 12 QL-transfectants, thereby establishing the critical role of STAT3 signaling in Ga 12 QL-mediated neoplastic cell growth. Thus, our studies presented here demonstrate for the first time that the gep oncogene, Ga 12 , integrates multiple signaling inputs in the activation of STAT3 and that STAT3 is a critical effector molecule for the oncogenic transformation induced by the gep oncogene.
Results
Activated mutant of Ga 12 QL stimulates the phosphorylation of STAT3 in multiple cell types Previously we have shown that the expression of PDGFRa was stimulated in NIH3T3 cells expressing the activated mutant of Ga 12 (Kumar et al., 2004) . Since PDGFs and PDGFRs have been shown to stimulate the activation of STAT3 (Cirri et al., 1997) , we investigated whether STAT3 functions downstream of PDGFRa in mediating the neoplastic transformation induced by the activated mutant of Ga 12 . We began by investigating whether STAT3 is stimulated in NIH3T3 cells stably expressing the activated mutant of Ga 12 (Ga 12 Q229L or Ga 12 QL) compared to the vector control cells (pcDNA3-NIH3T3). NIH3T3 cells, transformed by the stable expression of Ga 12 QL-NIH3T3 (Ga 12 QL-NIH3T3), were serum-starved for 24 h and the lysates from these cells were subjected to immunoblot analysis to verify the expression of Ga 12 (Figure 1a) or PDGFRa ( Figure 1b ) using antibodies raised against Ga 12 or PDGFRa, respectively. The results confirmed our previous findings that Ga 12 QL-NIH3T3 cells show an increase in the expression of PDGFRa (Kumar et al., 2004) . When the lysates from these cells were subjected to further immunoblot analysis with antibodies specific to STAT3 phosphorylated at ), the results indicated that the tyrosinephosphorylation of STAT3 is enhanced in Ga 12 QL-NIH3T3 cells (Figure 1c ). The blot was reprobed with antibodies to total STAT3 to monitor its expression levels ( Figure 1c) . A similar analysis to examine the phosphorylation of STAT5 in these cells indicated that there was little or no increase in the phosphorylation of STAT5 in Ga 12 QL-NIH3T3 cells compared to the pcDNA3-vector control group (data not shown).
In order to establish that the stimulation of STAT3 is in response to the signaling pathway(s) activated by Ga 12 and not due to the clonal variation of Ga 12 QL-NIH3T3 cells or the consequence of the transformed phenotype, we carried out transient expression studies using parental NIH3T3 cells. NIH3T3 cells were transiently transfected with an expression vector containing a cDNA-insert encoding Ga 12 QL or the empty vector using cationic lipid transfection reagent. Lysates from these transfectants were resolved by SDS-PAGE and examined for the activation of STAT3 by immunoblot analyses with antibodies to STAT3 phosphorylated at Tyr-705 (phospho-STAT3 TYR705 ) antibodies. The blot was reprobed with total STAT3 to monitor the expression levels. Results from these analyses clearly indicated that the transient expression of Ga 12 QL stimulated the activation of STAT3 (Figure 2a) .
To further define whether the observed increase in the activation of STAT3 by the activated mutant of Ga 12 is cell-type specific, we carried out transient transfection studies using COS-7 and HEK293 cells. Expression vector encoding Ga 12 QL or the empty vector was transfected into COS-7 cells or HEK-293 cells. The cells were lysed at 48 h after transfection and the lysates were subjected to immunoblot analysis with antibodies to phospho-STAT3 TYR705 to monitor the phosphorylation of STAT3 at Tyr-705. After profiling the phosphoryla- Figure 1 Ga 12 QL stimulates the activation of STAT3. (a) Lysates (50 mg) from pcDNA3-NIH3T3 and Ga 12 QL-NIH3T3 cells, prepared as described under Material and methods were separated by 10% SDS-PAGE and subjected to immunoblot analysis using Ga 12-antibody (which recognizes both the wild-type and GTPase deficient mutant, Ga 12 QL). The blot was stripped and re-probed with GAPDH antibody to monitor equal loading of proteins. (b) Lysates (50 mg) from 24-h serum-starved pcDNA3-and Ga 12 QL-NIH3T3 cells were subjected to immunoblot analysis using antibodies to PDGFRa. To monitor the loading control, the blot was stripped and reprobed with antibody raised against GAPDH. (c) Lysates (50 mg) from 24-h serum-starved pcDNA3-and Ga 12 QL-NIH3T3 cells were subjected to immunoblot analysis using antibodies to STAT3 TYR705 . To monitor the loading control, the blot was stripped and reprobed with antibody raised against STAT3. encoding Ga 12 QL as described under the Materials and methods section. Lysates (50 mg) were subjected to immunoblot analysis using antibodies to STAT3 TYR705 . To monitor the loading control, the blot was stripped and re-probed with antibody raised against STAT3. The blots were further probed with antibodies to Ga 12 monitor Ga 12 QL-expression.
STAT3 in Ga 12 signaling RN Kumar et al tion status of STAT3, the blots were stripped and reprobed to monitor the expression levels of total STAT3. Results from these analyses indicated that the activated mutant of Ga 12 stimulates the activation of STAT3 in both COS-7 ( Figure 2b ) and HEK-293 cells (Figure 2c ), thereby suggesting that the stimulation of STAT3 phosphorylation by Ga 12 QL is cell type independent.
PDGFRa and STAT3 associate with each other in vivo Previous studies have shown that the stimulation of NIH3T3 cells with PDGF leads to the activation of STAT3 . In addition, it has been shown that in the case of PDGFRb, the activated receptor associates with STAT(s) and this association promotes the stimulation of respective STAT proteins (Valgeirsdottir et al., 1998; Wang et al., 2000) . Since our results presented here show that Ga 12 QL stimulates the expression of PDGFRa ( Figure 1 ) as well as the phosphorylation of STAT3 (Figures 1 and 2 ), we hypothesized that the increased expression of PDGFRa plays a similar role in activating STAT3. To test this, Ga 12 QL-and pcDNA3-NIH3T3 cells were serumstarved for 24 h and PDGFRa was immunoprecipitated from the cell lysates using antibodies specific to PDGFRa. The immunoprecipitates, resolved by SDS-PAGE, were examined for the association of STAT3 by immunoblot analysis using antibodies to STAT3. The immunoblot analysis indicated that Ga 12 QL stimulated the association of STAT3 to PDGFRa (Figure 3a ).
Immunoprecipitation using antibodies to STAT3 followed by immunoblot analysis with PDGFRa using the same lysates further confirmed the association between STAT3 and PDGFRa in Ga 12 QL expressing cells ( Figure 3b ). To test whether the activation of PDGFRa is essential for its association with STAT3, the cells were treated with PDGFR-specific inhibitor AG1296. PDGFRa was immunoprecipitated from the cell lysates using antibodies to PDGFRa. The immunopreciptates were resolved by SDS-PAGE. The presence of PDGFRa in the immunoprecipitates was monitored by immunoblot analysis with PDGFRa-antibodies ( Figure 3c ; IB: PDGFRa). After verifying the ability of AG1296 to inhibit the phosphorylation of PDGFRa by immunoprobing the blot with phospho-tyrosine antibodies ( Figure 3c ; IB: p-Tyr), we proceeded to look at the presence of STAT3 in PDGFRa immunoprecipitates was monitored by immunoblot analysis using antibodies to STAT3. Results from such analyses indicated that the association between STAT3 and PDGFRa is decreased in the presence of AG1296 ( Figure 3c ; IB: STAT3), suggesting that the phosphorylation of PDGFRa is essential for the association of STAT3.
Src and JAK3 play a role in the tyrosine phosphorylation of STAT3
With the findings that Ga 12 QL stimulates the phosphorylation of Tyr-705 of STAT3, we were interested in defining the underlying mechanism. Since our results have indicated a physical interaction between PDGFRa and STAT3 (Figure 3 ), we examined whether PDGFRa is involved in the Tyr-705 phosphorylation of STAT3. Ga 12 QL-and pcDNA3-NIH3T3 cells were treated with PDGFR-specific inhibitor AG1296 (5 mM) for 16 h prior to lysis. Cell lysates were prepared and the tyrosine phosphorylation of STAT3 was monitored by immunoblot analysis using antibodies that can detect the Tyr-705-phosphorylated STAT3 (phospho-STAT3 TYR705 ). As shown in Figure 4a , the PDGFR-specific inhibitor AG1296 failed to inhibit Tyr-705 phosphorylation suggesting that a tyrosine kinase(s), other than PDGFR is involved in Tyr-705 phosphorylation of STAT3.
Previous studies have implicated both JAK3 and Src kinase in the activation of STAT3 by other Ga families such as Ga q , Ga s , and Ga i (Ram et al., 2000; Ram and Iyengar, 2001; Lo et al., 2003; Lo and Wong, 2004) . Therefore, we examined whether Ga 12 -stimulated phosphorylation of STAT3 involves these kinases. To assess the role of JAK3 and Src in the activation of STAT3, Ga 12 QL-and pcDNA3-NIH3T3 cells were treated with selective inhibitors against JAK3 (WHI-P154; 10 mM) or Src (PP2; 10 mM) for 2 h prior to the lysis of the cells. Cell lysates were prepared and the tyrosine phosphorylation of STAT3 was monitored by immunoblot analysis using antibodies that can detect the Tyr-705 phosphorylated STAT3 (phospho-STAT3 TYR705 ). The results indicated that both JAK3-and Src inhibitors inhibited the phosphorylation of STAT3 at Tyr-705, suggesting that the Tyr-705 phosphorylation of STAT3 Figure 3 STAT3 associates with PDGFRa in vivo. Lysates (500 mg) extracted from 24-h serum starved pcDNA3-and Ga 12 QL-NIH3T3 were subjected to immunoprecipitation using (a) anti-PDGFRa antibodies and (b) anti-STAT3. The immunoprecipitates were separated on 10% SDS-PAGE and immunoblot analysis was carried out using antibodies against STAT3 and PDGFRa. (c) Lysates (500 mg) extracted from 24-h serum starved pcDNA3-and Ga 12 QL-NIH3T3 either treated with 5 mM AG1296 overnight or with DMSO as vehicle control prior to lysis. The lysates were subjected to immunoprecipitation using anti-PDGFRa antibodies. The immunoprecipitates were separated on 10% SDS-PAGE and immunoblot analysis was carried out using antibodies against STAT3 and PDGFRa. (Yu et al., 1995; Bromberg et al., 1998; Turkson et al., 1998 Turkson et al., , 1999 Garcia et al., 2001) , our demonstration that they are recruited by the gep oncogene, Ga 12 , to stimulate the phosphorylation of STAT3 at Tyr-705 is a highly significant and novel finding.
Ga 12 stimulates the serine phosphorylation of STAT3 via PDGFRa and PI3K pathway In addition to the phosphorylation of Tyr-705, it has been observed that the activation of STAT3 involves the phosphorylation at a specific Serine residue, Ser-727 . As this Serine residue is in the Cterminal transactivation domain of STAT3, it has been proposed that the phosphorylation of Ser-727, in addition to the tyrosine phosphorylation at Tyr-705, is required for the maximal transcriptional activity of STAT3 . Therefore, we investigated whether the phosphorylation of Ser-727 is stimulated in Ga 12 QL-NIH3T3 cells. Lysates from 24-h serumstarved Ga 12 QL-or pcDNA3-NIH3T3 cells were subjected to immunoblot analysis to monitor the phosphorylation status of Ser-727 of STAT3 using antibodies specific to STAT3 phosphorylated at Ser-727 (phospho-
STAT3 SER727
). Results from such analysis indicated that the activated mutant of Ga 12 also stimulates the Ser-727 phosphorylation of STAT3 (Figure 5a ).
The signaling pathways leading to Ser-727 phosphorylation has been shown to be context-and cell-type specific. Depending on the physiological context and cell types, the phosphorylation of Ser-727 of STAT3 is mediated by different Ser/Thr kinases such as ATM, MEKK1, MKK4, ERKs, JNK, PKCd, as well as a pathway involving PI3K-AKT-mTOR (Jain et al., 1999; Kuroki and O'Flaherty, 1999; Turkson et al., 1999; Yokogami et al., 2000; Schuringa et al., 2001; Fung et al., 2003; Zhang et al., 2003) . Since PI3K-AKT signaling has been shown to play a role in Ser-727 phosphorylation of STAT3 (Fung et al., 2003) , we sought to determine whether PI3K-mediated signaling pathway is involved. Ga 12 QL-and pcDNA3-NIH3T3 cells were treated with PI3K-inhibitor wortmannin (500 nM) for 2 h prior to lysis. Lysates from these cells were subjected to immunoblot analysis with phospho-STAT3 SER727 antibodies. The results indicated that wortmannin potently inhibited the phosphorylation of STAT3 at Ser-727 (Figure 5a ), suggesting that PI3K-signaling is required for Ser-727 phosphorylation.
After establishing that PI3K-activity is required for the phosphorylation of STAT3 at Ser-727, we sought to investigate the signaling link between Ga 12 and PI3K-mediated Ser-727-phosphorylation of STAT3. In this context, it is interesting to note that that Ga 12 stimulates the expression of PDGFRa and the activated PDGFRa associates with STAT3 (Figure 3 ). In addition, it has been shown that the activation of PDGFRa leads to the association and activation of PI3K (Yu et al., 1994) . It has also been shown that PDGFA, presumably through PDGFRa, stimulates STAT3 (Valgeirsdottir et al., 1998) . Based on these findings, we hypothecized that it is possible that PDGFRa, through its downstream PI3K-AKT pathway, plays a role in the Ser-727 phosphorylation of STAT3. To evaluate such a role, Ga 12 QL-and pcDNA3-NIH3T3 cells were treated with PDGFR-specific inhibitor AG1296 (5 mM) for 16 h prior to the lysis of the cells. The lysates were subjected to immunoblot analysis with antibodies to phospho-STAT3 SER727 . The results indicated that the PDGFRinhibitor AG1296 inhibited the phosphorylation of STAT3 at Ser-727 (Figure 5b) , suggesting that the Ser-727 phosphorylation involves signaling from PDGFRa.
STAT3 is involved in Ga 12 -mediated oncogenic transformation of NIH3T3 cells
Having established that STAT3 is activated by Tyr-705 and Ser-727 phosphorylations by Ga 12 QL, we next examined whether the phosphorylated STAT3 is functionally active. As phosphorylated STAT3 binds to specific DNA-binding elements to activate the transcription of growth-promoting genes, we investigated the functional activity of STAT3 in these cells by monitoring its DNA-binding ability through electro-mobility shift assay (EMSA). Nuclear extracts from Ga 12 QL-and pcDNA3-NIH3T3 cells were incubated with radiolabeled STAT3-specific oligonucleotide duplex. Mutant oligonucleotides were used to monitor the specificity of STAT3-DNA binding. The increased STAT3-DNA complex seen with Ga 12 QL-nuclear extracts incubated with STAT3-specific oligonucleotides indicate that the DNA binding ability of STAT3 is enhanced in Ga 12 QL-NIH3T3 cells (Figure 6a , Lane 2 versus 1). The absence of protein-DNA complex in nuclear extracts incubated with mutant oligonucleotides confirms the specificity of STAT3-DNA interaction in these cells (Figure 6a , Lane 3 and 4). Thus, these results demonstrate that the phosphorylated STAT3 in Ga 12 QL-NIH3T3 cells is functionally active. Activated Ga 12 has been shown to be involved in the oncogenic transformation of NIH3T3 cells (Jiang et al., 1993; Xu et al., 1993; Prasad et al., 1995) . It is interesting to note that STAT3 plays a pivotal role in Src-mediated transformation of fibroblast cell lines (Bromberg et al., 1998; Turkson et al., 1998) . Therefore, we investigated whether the activation of STAT3 plays a role in Ga 12 QL-mediated neoplastic transformation. Neoplastic transformation by the gep oncogene Ga 12 -similar to other oncogenes -is characterized by loss of contact inhibition as well as anchorage-independence of growth (Chan et al., 1993; Jiang et al., 1993; Xu et al., 1993; Vara Prasad et al., 1994; Voyno-Yasenetskaya et al., 1994) . To test whether STAT3 plays a role in Ga 12 QL-mediated loss of contact inhibition of cell growth, we carried out focus formation assay. Parental NIH3T3 cells were transfected with vectors encoding Ga 12 QL along with or without the dominant-negative mutant of STAT3 (STAT3DB). Appropriate control groups were included and the foci formed by these transfectants were scored after 14 days. The results indicated that NIH3T3 cells harboring Ga 12 QL formed foci (Figure 6b ) in accordance with the previous findings (Jiang et al., 1993; Xu et al., 1993; Prasad et al., 1995) . However, the focus forming ability of Ga 12 QL was drastically inhibited in the presence of the dominant-negative mutant of STAT3 (Figure 6b ). Graphical representation of the results indicates that there is a 58% decrease in the focus forming ability of Ga 12 in the presence of dominant-negative STAT3 (Figure 6c) . Furthermore, to test whether STAT3 is involved in Ga 12 QL-mediated anchorage-independent cell growth, we carried our soft-agar colony formation assay. Parental NIH3T3 cells were transfected with vectors encoding Ga 12 QL along with or without the dominantnegative mutant of STAT3. The transfected cells were STAT3 in Ga 12 signaling RN Kumar et al plated on soft agar. The number of colonies formed on the soft-agar after 21 days was determined. Consistent with the previous observations (Jiang et al., 1993; Xu et al., 1993; Prasad et al., 1995) , the cells harboring Ga 12 QL formed colonies on soft agar (Figure 6d) . However, when the cells were cotransfected with the dominant-negative mutant of STAT3, the ability to form colonies on soft agar was greatly reduced (Figure 6d) . The results indicate that the ability of Ga 12 QL cells to form colonies on soft agar was reduced by 28% in the presence of the dominant-negative mutant of STAT3. Taken together, these findings indicate that STAT3 plays a critical role in Ga 12 QLmediated neoplastic transformation.
Discussion
In many human cancers, STAT3 has been identified to be persistently activated (Garcia et al., 2001; Li and Shaw, 2002; Pedranzini et al., 2004) . In this context, our findings that STAT3 is activated by the gep oncogene Ga 12 is of great significance. Considering the potent transforming activity of Ga 12 (Radhika and Dhanasekaran, 2001 ), these observations indicate a critical role for STAT3 in Ga 12 -mediated oncogenic pathway. Our findings show that activated Ga 12 is capable of stimulating STAT3 through a mechanism involving multiple signaling pathways. Our studies presented here indicate that Tyr-705 phosphorylation of STAT3 involves Src and JAK3 as indicated by the inhibition of the Tyr-705 phosphorylation by the Src inhibitor, PP2 and the JAK3 inhibitor, WHI P154, respectively (Figure 4b ). This is in accordance with the previous findings that Src and JAK3 are involved in the activation of STAT3 (Yu et al., 1995; Bromberg et al., 1998; Turkson et al., 1999; Garcia et al., 2001 ). In addition, it has been shown that Ga 12 stimulates Src through a Rho-dependent pathway (Nagao et al., 1999) . Furthermore, our previous studies have shown that Ga 12 stimulates the expression of JAK3 and that JAK3 is involved in Ga 12 -mediated cell proliferation (Kumar et al., 2004) . Taken together, our results presented here establish that the activated Ga 12 recruits Src and JAK3 kinases to phosphorylate STAT3 at Tyr-705.
It is significant to note here that STAT3 requires the phosphorylation at Ser-727 in addition to that of Tyr-705 for its maximal transcriptional activity . An interesting observation presented here is that the receptor tyrosine kinase PDGFRa physically associates with STAT3 and the inhibition of PDGFRa leads to a decrease in its association with STAT3. However, our results indicate that this association does not play a role in the Tyr-705 phosphorylation of STAT3. Although this observation is consistent with the canonical view that STAT3 binds to phosphorylated residues of the receptor tyrosine kinases (RTKs) via the SH2 domains (Yamanaka et al., 1996; Chakraborty et al., 1999) , the finding that this association does not play a role in the Tyr-phosphorylation of STAT3 is rather surprising. However, it is possible that the Tyr-705 phosphorylation of STAT3 by PDGFRa is an acute response that can be substituted by Src and JAK3 at the later time point at which the observations were made. While we do not see the inhibition of Tyr-705 in the presence of the PDGFR-inhibitor AG1296 at 16 h after the inhibitor treatment, our results do indicate that Ser-727 phosphorylation of STAT3 is inhibited by AG1296 as well as by PI3K inhibitor, wortmannin. Recent studies have shown that PI3K can be activated by PDGFRa (Yu et al., 1994) and activated PI3K, presumably through AKT, is involved in the phosphorylation of STAT3 at Ser-727 (Fung et al., 2003) . It is significant to note here that at least in the case of PDGFRb, PDGFRb acts as a scaffold for STAT5 to facilitate its phosphorylation by other PDGFRb-interacting kinases. Therefore, it is likely that the activated PDGFRa acts as a scaffold for STAT3 so that PI3K-AKT signaling pathway can stimulate the Ser-727 phosphorylation of STAT3. The finding that a receptor tyrosine kinase, PDGFRa facilitates the phosphorylation of the Ser-residue is quite significant.
Based on the previous observation that that the phosphorylation of Tyr-705 precedes the Ser-727 phosphorylation of STAT3 (Boulton et al., 1995) , a temporal sequence of signaling events leading to the activation of STAT3 can be constructed in which (1) Ga 12 stimulates the Tyr-phosphorylation of STAT3 via Src and JAK3; (2) the Tyr-705 phosphorylated STAT3 associates with Ga 12 QL-stimulated PDGFRa; and (3) activated PDGFRa serves as a scaffold for STAT3 to facilitate the phosphorylation of the Ser-727 residue through a pathway involving PI3K (Figure 7) . Thus, Ga 12 appears to ensure the maximal activation of STAT3 in these cells by stimulating the phosphorylation of both Tyr-707 and Ser-727 by stimulating parallel signaling pathways resulting in the activation of STAT3.
It is interesting to note here that the overexpression of STAT3 leads to the neoplastic transformation of NIH3T3 cells (Turkson et al., 1998; Bromberg et al., 1999) . It has been shown that the coexpression of dominant-negative mutant of STAT3 inhibits Srcmediated focus formation and growth of transformed NIH3T3 cells on soft agar (Turkson et al., 1998; Bromberg et al., 1999) . Our present findings that coexpression of the dominant negative, DNA-binding deficient mutant of STAT3, inhibits Ga 12 QL mediated oncogenic transformation unravels the critical role of STAT3 in Ga 12 mediated oncogenic pathway. Taken together with the observations that Ga 12 is overexpressed and activated in several breast and ovarian cancer cells (Radhika, Ha, and Dhanasekaran, unpublished observations; Gutkind et al., 1998) and that STAT3 is persistently activated in ovarian and breast cancer cells (Huang et al., 2000; Berclaz et al., 2001; Burke et al., 2001; Garcia et al., 2001) , our results showing that Ga 12 stimulates STAT3, identify a novel signaling link that may play a role in the etiology of these cancers. Further studies are being carried out to define this signaling nexus involving Ga 12 , PDGFRa, and STAT3 in the genesis and/or progression of ovarian and breast cancers.
Materials and methods
Cell lines and cell culture Parental NIH3T3, pcDNA3-NIH3T3, and Ga 12 Q229L-NIH3T3 cells were maintained as described previously (Prasad et al., 1995) . Cos-7 and HEK293 cells were maintained in DMEM containing 5% fetal bovine serum. Transient expression of Ga 12 QL in COS-7 cells was carried out by transfecting the cells (0.7 Â 10 6 cells/60 mm dish), with appropriate expression vectors using Lipofectamine 2000 reagent (Invitrogen Technologies, CA, USA), whereas transfection of HEK293 cells (0.7 Â 10 6 cells/60 mm dish) were carried out using calcium phosphate transfection method (Vara Prasad et al., 1994) . Cells were collected and lysed with modified RIPA buffer (50 mM Tris-HCl 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 1 mM sodium vanadate, 2 mg/ml leupeptin, 4 mg/ml aprotinin, 1 mM NaF, and pH 7.4) at 24 h post-transfection.
Immunoprecipitations and Western blot analysis
Immunoprecipitation of PDGFRa, STAT3, or tyrosinephosphorylated proteins was carried out by incubating cell lysate protein (1 mg each) with 1 mg of respective antibodies for 16 h at 41C followed by the incubation with 20 ml of 50% slurry of protein-A Sepharose beads (Amersham Biosciences Corp., Piscataway, NJ, USA) for 2 h at 41C. After repeated washes with cell lysis buffer, the immunoprecipitated proteins were separated by SDS-PAGE and electro-blotted onto PVDF membranes for immunoblot analysis. Antibodies to Ga 12 (sc-409) and PDGFRa (sc-338) were purchased from Santa Cruz Biotechnology, Inc., CA, USA. Antibodies to phospho-STAT3-Tyr705 (#9131), phospho-STAT3-Ser727 (#9134), and STAT3 (#9132) were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA), whereas antibodies to phosphotyrosine (clone 4G10, #05-321) was purchased from Upstate Signaling Solutions (Charlottesville, VA, USA). Antibodies to GAPDH (#4300) was purchased from Ambion, Inc. (Austin, TX, USA). Peroxidase-conjugated anti-mouse IgG and anti-rabbit IgG were from Amersham Biosciences UK limited (Buckinghamshire, England) and Promega (Madison, WI, USA) respectively.
Electro-mobility shift assay (EMSA) Nuclear extracts from pcDNA3-and Ga 12 QL-NIH3T3 cells were prepared according to the previously published procedures (Sambrook and Russell, 2001 ). The STAT3 consensus oligonucleotides (sc-2571) and the STAT3 mutant oligonucleotide (sc-2572) used in the gel shift assay were purchased from Santa Cruz Biotechnology, Inc., CA, USA. The annealed double-stranded oligonucleotides (25 pmol) were end-labeled with 20 mM [g-32 P]ATP (6000 Ci/mmol) and purified by G-25 spin columns (Amersham Pharmacia, Piscataway, NJ, USA). Nuclear extracts (5 mg) was mixed with 1 mg of salmon sperm DNA (Gibco BRL, CA, USA) and incubated with 50 000 c.p.m. of radio-labeled probes with or without unlabeled competitor probes. DNA-protein complexes were resolved on a 5% nondenaturing PAGE in 0.25 Â TBE (50 mM Tris, 50 mM boric acid, and 1 mM EDTA) following the previously published procedures (Sambrook and Russell, 2001) . The gels were dried and subjected to autoradiography.
Focus formation assay NIH3T3 cell focus formation assay was carried out as previously described (Shore and Reddy, 1989) . The dominant negative, DNA-binding mutant of STAT3 (STAT3DB) was a generous gift from Dr E Premkumar Reddy (Fels Institute for Cancer Research, PA, USA). Parental NIH3T3 cells were Figure 7 Schematic of Ga 12 -mediated STAT3 activation. Activated Ga 12 stimulates tyrosine-705 phosphorylation of STAT3 (represented by circled pY) via a pathway involving JAK3 and Src pathway. PDGFRa, whose expression levels and activity are increased in cells expressing activated Ga 12 , associates with STAT3 to promote Serine-727 phosphorylation of STAT3 through a signaling pathway involving PI3K. The Tyr-and Ser-phosphorylated STAT3 binds to specific response elements in the DNA, activating the transcription of specific genes, to promote neoplastic cell growth.
transfected with pcDNA3-vectors encoding Ga 12 QL (5 mg) or pcDNA3 vector along with or without STAT3DB (5 mg) using the calcium phosphate transfection method. Transfected NIH3T3 cells were cultured in the presence of 5% serum, and transformed foci were stained and scored after 14 days.
Soft agar assay
To 2.5 ml of 2 Â DMEM, equal volume of 1% Noble agar (Difco) in sterile water was added and mixed to obtain a total volume of 5 ml. This solution was layered into the bottom of a 60 mm cell-culture dish. The agar was allowed to solidify. To this agar-layered culture-dish, the top agar containing cells were overlayed as follows. To 1.5 ml of 2 Â DMEM, equal volume of 0.7% Noble agar solution was mixed to obtain a total volume of 3 ml. This top agar was left at 421C. NIH3T3 cells were transfected with pcDNA3-vector or pcDNA3 vector encoding Ga 12 QL (5 mg) along with or without STAT3DB (5 mg) were added using the calcium phosphate transfection method (Shore and Reddy, 1989) . The transfected NIH3T3 cells (5 Â 10 4 cells in 100-200 ml of DMEM) were added into the top-agar mixture and uniformly overlayed on the bottom agar layer.
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